Influence of the protein kinase C inhibitor 3-{1-[3-(amidinothio)propyl]-1H-indoyl-3-yl}-3-(1-methyl-1H-indoyl-3 -yl)maleimide methane sulfonate (Ro-318220) on surfactant secretion in type II pneumocytes

Biochemical Pharmacology

Volumn 53, Issue 4, 1997, Pages 597-601

  Rooney, Seamus A ^a   Gobran, Laurice I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lung surfactant; phosphatidylcholine secretion; protein kinase C inhibitor; signal transduction; surfactant secretagogues; type II pneumocyte

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE TRIPHOSPHATE; DIOCTANOIN; IONOMYCIN; LUNG SURFACTANT; PHORBOL ESTER; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TERBUTALINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LUNG ALVEOLUS CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SECRETION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; ENZYME INHIBITORS; INDOLES; LUNG; MALE; PHOSPHATIDYLCHOLINES; PROTEIN KINASE C; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; TETRADECANOYLPHORBOL ACETATE;

EID: 0031581868     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00827-1     Document Type: Article

References (31)

1. 1. Rooney SA, Young SL and Mendelson CR, Molecular and cellular processing of lung surfactant. FASEB J 8: 957-967, 1994.
2. 2. Pison U, Max M, Neuendank A, Weißbach S and Pietschmann S, Host defence capacities of pulmonary surfactant: Evidence for 'non-surfactant' functions of the surfactant system Eur J Clin Invest 24: 586-599, 1994.
3. 3. Chander A and Fisher AB, Regulation of lung surfactant secretion. Am J Physiol 258: L241-L253, 1990.
4. 4. Wright JR and Dobbs LG, Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol 53: 395-414, 1991.
5. 2 purinoceptor-stimulated surfactant phospholipid secretion in primary cultures of rat type II pneumocytes. Lung 171: 75-86, 1993.
6. 6. Griese M, Gobran LI and Rooney SA, Signal-transduction mechanisms of ATP-stimulated phosphatidylcholine secretion in rat type II pneumocytes; Interactions between ATP and other surfactant secretagogues. Biochem Biophys Acta 1167: 85-93, 1993.
7. 7. Cohen P, Signal integration at the level of protein kinases, protein phosphatases and their substrates. Trends Biochem Sci 17: 408-413, 1992.
8. 8. Rooney SA and Gobran LI, Activation of phospholipase D in rat type II pneumocytes by ATP and other surfactant secretagogues. Am J Physiol 264: L133-L140, 1993.
9. 9. Hidaka H and Kobayashi R, Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol 32: 377-397, 1992.
10. 10. Casnellie JE, Protein kinase inhibitors: Probes for the functions of protein phosphorylation. Adv Pharmacol 22: 167-205, 1991.
11. 11. MacKintosh C and MacKintosh RW, Inhibitors of protein kinases and phosphatases. Trends Biochem Sci 19: 444-448, 1994.
12. 12. Wilkinson SE and Hallam TJ, Protein kinase C: Is its pivotal role in cellular activation over-stated? Trends Pharmacol Sci 15: 53-57, 1994.
13. 13. Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D and Wilkinson SE, Potent selective inhibitors of protein kinase C. FEBS Lett 259: 61-63, 1989.
14. 14. Dobbs LG, Gonzalez R and Williams MC, An improved method for isolating type II cells in high yield and purity. Am Rev Respir Dis 134: 141-145, 1986.
15. 15. Griese M, Gobran LI and Rooney SA, Ontogeny of surfactant secretion in type II pneumocytes from fetal, newborn, and adult rats. Am J Physiol 262: L337-L343, 1992.
16. 1 receptor-mediated inhibition of surfactant secretion in rat type II pneumocytes. Am J Physiol 258: L45-L51, 1990.
17. 17. Bligh EG and Dyer WJ, A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
18. 18. Tallarida RJ and Murray RB, Manual of Pharmacologic Calculations with Computer Programs. Springer, New York, 1987.
19. 19. Newton AC, Protein kinase C: Structure, function, and regulation. J Biol Chem 270: 28495-28498, 1995.
20. 20. Nishizuka Y, Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496, 1995.
21. 2 receptor regulation of phosphatidylcholine secretion in cultured type II pneumocytes. J Pharmacol Exp Ther 241: 907-914, 1987.
22. 22. Rice WR, Hull WM, Dion CA, Hollinger BA and Whitsett JA, Activation of cAMP dependent protein kinase during surfactant release from type II pneumocytes. Exp Lung Res 9: 135-149, 1985.
23. 23. Warburton D, Buckley S and Cosico L, P1 and P2 purinergic receptor signal transduction in rat type II pneumocytes. J Appl Physiol 66: 901-905, 1989.
24. 2u purinoceptor stimulation of surfactant secretion coupled to phosphatidyl-choline hydrolysis in type II cells. Am J Physiol 267: L625-L633, 1994.
25. 2u-purinergic receptor. Am J Respir Cell Mol Biol 12: 27-32, 1995.
26. 2 purine receptor interactions and surfactant secretion in primary cultures of type II cells. Am J Physiol 261: L140-L147, 1991.
27. 27. Griese M, Gobran LI and Rooney SA, ATP-stimulated inositol phospholipid metabolism and surfactant secretion in rat type II pneumocytes. Am J Physiol 260: L586-L593, 1991.
28. 2-purinoceptor regulation of surfactant phosphatidylcholine secretion. Relative roles of calcium and protein kinase C. Biochem J 266: 407-413, 1990.
29. 29. Berridge MJ and Irvine RF, Inositol phosphates and cell signalling. Nature 341: 197-205, 1989.
30. 30. Voyno-Yasenetskaya TA, Dobbs LG and Williams MC, Regulation of ATP-dependent surfactant secretion and activation of second-messenger systems in alveolar type II cells. Am J Physiol 261(Suppl): 105-109, 1991.
31. 31. Liu JP, Protein kinase C and its substrates. Mol Cell Endocrinol 116: 1-29, 1996.